The world is changing for Big Pharma. Driven by value-based care, reimbursement will increasingly be tied to drug effectiveness and outcomes. Competition is growing and market share slipping. To offset these challenges, pharma must forge new strategic alliances, drive efficiencies, speed up clinical trials, and develop targeted therapies as healthcare moves to more personalized care and precision medicine. Technology will drive this paradigm shift.
For this session, HIMSS has assembled a panel of industry thought-leaders to discuss the current state of pharma-payer-provider collaborations. Importantly, the panel will address the question that seems top of mind for many in the pharmaceutical industry: What do healthcare providers expect of pharmaceutical companies in the new healthcare ecosystem?
• What are the opportunities for all stakeholders, including patients?
• How will health IT will help drive this new business model?
• How can all stakeholders work together to improve patient access, experience and outcomes?